JP2012513193A5 - - Google Patents

Download PDF

Info

Publication number
JP2012513193A5
JP2012513193A5 JP2011541487A JP2011541487A JP2012513193A5 JP 2012513193 A5 JP2012513193 A5 JP 2012513193A5 JP 2011541487 A JP2011541487 A JP 2011541487A JP 2011541487 A JP2011541487 A JP 2011541487A JP 2012513193 A5 JP2012513193 A5 JP 2012513193A5
Authority
JP
Japan
Prior art keywords
antibody
seq
tfpi
amino acids
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011541487A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012513193A (ja
JP5791512B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/067566 external-priority patent/WO2010072687A1/en
Publication of JP2012513193A publication Critical patent/JP2012513193A/ja
Publication of JP2012513193A5 publication Critical patent/JP2012513193A5/ja
Application granted granted Critical
Publication of JP5791512B2 publication Critical patent/JP5791512B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011541487A 2008-12-22 2009-12-18 組織因子経路阻害因子（ｔｆｐｉ）に対する抗体 Expired - Fee Related JP5791512B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08172522 2008-12-22
EP08172522.8 2008-12-22
PCT/EP2009/067566 WO2010072687A1 (en) 2008-12-22 2009-12-18 Antibodies against tissue factor pathway inhibitor (tfpi)

Publications (3)

Publication Number Publication Date
JP2012513193A JP2012513193A (ja) 2012-06-14
JP2012513193A5 true JP2012513193A5 (https=) 2012-12-13
JP5791512B2 JP5791512B2 (ja) 2015-10-07

Family

ID=42104649

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011541487A Expired - Fee Related JP5791512B2 (ja) 2008-12-22 2009-12-18 組織因子経路阻害因子（ｔｆｐｉ）に対する抗体

Country Status (6)

Country Link
US (2) US8618263B2 (https=)
EP (1) EP2379599B1 (https=)
JP (1) JP5791512B2 (https=)
CN (1) CN102300876A (https=)
TW (1) TW201026329A (https=)
WO (1) WO2010072687A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2379600B2 (en) * 2008-12-22 2020-10-14 Novo Nordisk A/S Antibodies against tissue factor pathway inhibitor
HUE047173T2 (hu) 2010-03-01 2020-04-28 Bayer Healthcare Llc Optimalizált monoklonális ellenanyagok szöveti faktor útvonal inhibitor (TFPI) ellen
JP2013533871A (ja) * 2010-06-30 2013-08-29 ノヴォ ノルディスク アー／エス 組織因子経路インヒビターに特異的に結合することが可能な抗体
US9228022B2 (en) 2010-06-30 2016-01-05 Novo Nordisk A/S Antibodies that are capable of specifically binding tissue factor pathway inhibitor
JP6586016B2 (ja) 2013-03-15 2019-10-02 ノヴォ ノルディスク アー／エス 組織因子系凝固インヒビター上の２つのエピトープに特異的に結合することが可能な抗体
US10231993B2 (en) 2013-06-27 2019-03-19 University Of Washington Through Its Center For Commercialization Biocompatible polymeric system for targeted treatment of thrombotic and hemostatic disorders
US10457743B2 (en) 2013-07-19 2019-10-29 Novo Nordisk A/S Antibodies recognizing the N-terminal part of tissue factor pathway inhibitor capable of eliciting pro-coagulant activity
CN106687482B (zh) * 2014-09-17 2022-01-25 诺和诺德股份有限公司 能够结合组织因子途径抑制剂(1-161)上的两个表位的抗体
JP6660957B2 (ja) * 2015-02-25 2020-03-11 モガム インスティチュート フォー バイオメディカル リサーチＭＯＧＡＭ Ｉｎｓｔｉｔｕｔｅ ｆｏｒ Ｂｉｏｍｅｄｉｃａｌ Ｒｅｓｅａｒｃｈ 新規の抗−ｔｆｐｉ抗体及びこれを含む組成物
JP6664467B2 (ja) 2015-08-19 2020-03-13 ファイザー・インク 組織因子経路インヒビター抗体およびその使用
BR112021006223A2 (pt) 2018-10-11 2021-07-06 Pfizer regime de dosagem para antagonistas de inibidor da via de fator tecidual (tfpi)
CN112442127A (zh) * 2019-08-29 2021-03-05 苏州康宁杰瑞生物科技有限公司 针对tfpi的单克隆抗体
WO2025124481A1 (zh) * 2023-12-13 2025-06-19 苏州康宁杰瑞生物科技有限公司 Tfpi抗体用于治疗血友病

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0539975A1 (en) * 1991-10-31 1993-05-05 Teijin Limited Method for immunological assay of free lipoprotein-associated coagulation inhibitor (LACI) and kit therefor
JPH0875736A (ja) * 1994-09-06 1996-03-22 Chemo Sero Therapeut Res Inst ヒト組織因子凝固系インヒビターの定量法

Similar Documents

Publication Publication Date Title
JP2012513193A5 (https=)
JP2012505912A5 (https=)
NO20083793L (no) Antistoffer mot amyloid-beta peptid
RU2015120804A (ru) Антагонисты активина-actrii и их применение для лечения нарушений костной ткани и других нарушений
WO2008101985A3 (en) Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization
PH12019500644A1 (en) Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
JP2018168176A5 (https=)
JP2016529229A5 (https=)
CY1123008T1 (el) Συνθεσεις raav-γουανυλικης κυκλασης και μεθοδοι για τη θεραπευτικη αντιμετωπιση της συγγενους αμαυρωσης 1 toy leber (lca1)
EA201892184A1 (ru) Оптимизированные моноклональные антитела против ингибитора пути тканевого фактора
JP2010202664A5 (https=)
JP2016504275A5 (https=)
WO2009086539A3 (en) Treatment and prophylaxis of amyloidosis
JP2016521688A5 (https=)
AR086579A1 (es) Proteinas de union a antigeno
JP2008508859A5 (https=)
RU2534564C3 (ru) Мультиспецифическая связывающая антиген молекула, которая обладает альтернативной функцией к функции фактора свертывания крови viii
NZ599193A (en) Siglec 15 antibodies in treating bone loss-related disease
WO2010017196A3 (en) Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
HRP20161656T4 (hr) Sredstva za vezanje na cd33
EA201301107A1 (ru) Моноклональные антитела против ингибитора пути тканевого фактора (tfpi)
JP2018512124A5 (https=)
EA201290525A1 (ru) Новые антитела-антагонисты, их fab-фрагменты против gpvi и способы их применения
JP2013520996A5 (https=)
JP2012188436A5 (https=)